Simplex Trading’s Genocea Biosciences, Inc. GNCA Stock Holding History

Simplex Trading’s Portfolio GNCA Stock Details GNCA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-9,100	Closed	-$11K	–	11760
2022 Q1	$11K	Buy	+9,100	New	+$9.91K	﹤0.01%	8837
2021 Q4	–	Sell	-6,400	Closed	-$14K	–	12034
2021 Q3	$14K	Hold	6,400	–	–	﹤0.01%	8746
2021 Q2	$14K	Buy	6,400 +6,272	+4,900%	+$15.1K	﹤0.01%	8903
2021 Q1	$34K	Sell	128 -160	-56%	-$474	﹤0.01%	7027
2020 Q4	$69K	Buy	288 +184	+177%	+$419	﹤0.01%	5835
2020 Q3	$23K	Buy	104 +83	+395%	+$218	﹤0.01%	6290
2020 Q2	$4K	Buy	21 +11	+110%	+$25	﹤0.01%	7112
2020 Q1	$1K	Buy	+10	New	+$20	﹤0.01%	7488
2019 Q4	–	Sell	-54	Closed	-$15K	–	8460
2019 Q3	$15K	Sell	54 -75	-58%	-$256	﹤0.01%	6035
2019 Q2	$50K	Buy	+129	New	+$673	﹤0.01%	4872
2017 Q3	–	Sell	-1	Closed	-$1K	–	7083
2017 Q2	$1K	Hold	1	–	–	﹤0.01%	5897
2017 Q1	$1K	Buy	+1	New	+$39	﹤0.01%	5960

Other funds holding GNCA

AICPI

ABG Innovation Capital Partners III Central, Hong Kong, Hong Kong $64.5K AUM 1.01% 1-Year Est. Return

Simplex Trading's GNCA Position: Q3 2022 in Review

Simplex Trading sold out of Genocea Biosciences, Inc. (GNCA) in Q3 2022, closing a stake of 500 shares.

Simplex Trading first reported a position in GNCA in Q3 2016 and held it in 12 quarters. The position peaked at $37K in Q4 2020. 1 fund tracked by Wall St. Rank holds GNCA as of Q3 2022.

Simplex Trading reported no remaining Genocea Biosciences, Inc. position as of Q3 2022 after selling out during the quarter.
Simplex Trading sold 500 Genocea Biosciences, Inc. shares in Q3 2022.
Simplex Trading first reported a position in Genocea Biosciences, Inc. in Q3 2016 and held it in 12 quarters.
Simplex Trading's Genocea Biosciences, Inc. position peaked at $37K in Q4 2020.
1 fund tracked by Wall St. Rank held Genocea Biosciences, Inc. as of Q3 2022.

Based on Simplex Trading's 13F filing for Q3 2022, filed 4 Nov 2022.